30 closest matches · ranked by relevance
Dementia · Mild Cognitive Impairment
Primary: Documentation of PPC Discussion — 72; 106 Participants
Patient Computer Dialog
Primary: Patient Post Medical History Assessment Questionnaire — 8.4; 8.3 units on a scale
Type1 Diabetes
Primary: Number of Participants That Completed Interviews About Consultation Summaries They Were Receiving — 9 Participants
Recruitment
Primary: ACTNOW! Clinical Trial Knowledge Assessment Score — 93.89; 93.58; 94.88; 97.88 score
Sexually Transmitted Diseases
Primary: Number of Patients Recording Preferences to Restrict Provider Access to Some or All Electronic Health Record (EHR) Data — 45; 13 participants
Conflict · Decisional Conflict
Primary: Perceived Efficacy in Patient-Physician Interactions (PEPPI) Self-Efficacy Scale- Outcome Measure at Baseline, Post-test and One Month Follow-up — 44.6; 44.0; 44.3; 44.4…
Asthma
Primary: Difference Between Number of Families Who Adopted MyAsthma Portal Use and Number of Families With Sustained Use — 156; 81 participants
Asthma
Primary: Rate of Asthma Exacerbations Per Year — 0.69; 0.82 Adjusted annualized exacerbations — p=0.048
Prostate Cancer
Primary: Pca Risk-related Knowledge — 6.92; 7.19 units on a scale
Mental Disorders
Primary: Shared Decision Making (OPTION) Independent Blind Coder Assessment Scores — 36.31; 29.78; 34.50; 30.37 units on a scale
Oral Disease · Dental Caries
Primary: Number of Patients Who Agree or Strongly Agree With the Statement, "The Community Health Worker (CHW) Helped me to Improve How I Take Care of my Health" Based on a…
Peripheral Artery Disease
Primary: Enrollment in GAMEPAD Intervention Study — 39; 45 Participants
Depression
Primary: Acceptability of Intervention Measure — 4.13; 4.25; 3.69; 4.31 score on a scale — p=0.905
Kidney Diseases · Cardiometabolic Risk Factors
Primary: Acceptability Interviews (Investigator Developed) — 3; 2; 2; 2 Participants
Hyperlipidemia
Primary: Percentage of Participants With Positive Response on Increased Motivation Using a Self-test at Month 12 — 36.2 Percentage of participants
Advance Care Planning · Dementia
Primary: Number of Patients 65 and Older With New Documentation of Any Advance Directive in the Electronic Health Record (EHR) — 2190; 2130; 255; 409 Participants
Primary Care
Primary: Self-reported Bodily Pain — 2937; 1061; 1446; 2344 Participants
Diabetes Mellitus, Type 2 · Patient Education as Topic
Primary: Change in DSMQ Diabetes Self Management Questionnaire Measuring Diabetes Self Management Skills Pre and Post Intervention — .96; 1.08; .28; -.17 change score (difference…
Type II Diabetes
Primary: Priority Scores for Potential Barriers and Facilitators for Diabetes Self-management — 0.505; 0.327; 0.500; 0.369 units on a scale
Patient Engagement · Physician's Role · Physician-Patient Relationship
Primary: Patient Rating of Shared Decision Making — 66.7; 72.0; 74.7; 74.7 percentage of participants
Cancer
Primary: Knowledge About Cancer Clinical Trials — 73.4; 61.6 percentage questions answered correctly
Hepatitis C, Chronic · Liver Diseases
Primary: Change in the Total Memorial Symptom Assessment Scale Mean Score (TMSAS) From Baseline to On-Treatment — -0.10; -0.1 units on a scale
Other Cancer
Primary: Number of Participants With Advance Care Planning Documentation — 0; 1163; 349; 901 Participants — p=<0.05
Prostate Cancer
Primary: Physician Offers of a Clinical Trial — 14 Participants
Schizophrenia · Bipolar Disorder · Major Depression
Primary: Patient Experience of Medication Treatment (PEMM) — 3.009; 3.007; 2.6; 3.09 Units on a scale — p=<0.0001
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants Who Prioritized Healthcare Topics — 90; 79; 23; 22 participants — p=.91
Type II Diabetes
Primary: Patient Medication Preference as Estimated by a Choice Model — 0.983; 0.362; 0.284; 0.261 utility of
Primary Care
Primary: Consultation and Relational Empathy (CARE) Measure — 44.69; 41.99 units on a scale — p=0.029
Asthma
Primary: Rate of Asthma Exacerbations — 3.21 events/12 weeks
Active Breast Cancer Treatment
Primary: Between-group Differences in Patient Complete Illness Understanding at 9-months — 42; 38; 21; 17 Participants — p=0.264